Matches in Nanopublications for { ?s ?p "DDI between Brimonidine and Isocarboxazid - MAO Inhibitors like isocarboxazid may enhance the hypertensive effect of Alpha2-Agonists (Ophthalmic). The concomitant use of monoamine oxidase inhibitors and ophthalmic alpha2 agonists is contraindicated. [drugbank_resource:DB00484_DB01247]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB00484_DB01247 label "DDI between Brimonidine and Isocarboxazid - MAO Inhibitors like isocarboxazid may enhance the hypertensive effect of Alpha2-Agonists (Ophthalmic). The concomitant use of monoamine oxidase inhibitors and ophthalmic alpha2 agonists is contraindicated. [drugbank_resource:DB00484_DB01247]" assertion.